MASECO Private Wealth
TAK icon

MASECO Private Wealth’s Takeda Pharmaceutical TAK Stock Holding History

MASECO Private Wealth’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-316
Closed -$5.84K – 381
2026
Q1 		$5.84K Hold
316
– – ﹤0.01% 283
2025
Q4 		$4.92K Buy
+316
New +$4.52K ﹤0.01% 427
2025
Q3 		– Sell
-310
Closed -$4.79K – 483
2025
Q2 		$4.79K Buy
+310
New +$4.58K ﹤0.01% 401

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

MASECO Private Wealth's TAK Position: Q2 2026 in Review

MASECO Private Wealth sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 316 shares — an estimated $5.84K sold.

MASECO Private Wealth first reported a position in TAK in Q2 2025 and held it in 3 quarters. The position peaked at $5.84K in Q1 2026. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • MASECO Private Wealth reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • MASECO Private Wealth sold 316 Takeda Pharmaceutical shares in Q2 2026, an estimated $5.84K.
  • MASECO Private Wealth first reported a position in Takeda Pharmaceutical in Q2 2025 and held it in 3 quarters.
  • MASECO Private Wealth's Takeda Pharmaceutical position peaked at $5.84K in Q1 2026.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on MASECO Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.